Dec 30, 2025 08:00AM Cadrenal's Pipeline Looks Less Like a Microcap and More Like an Emergency Response System

Dec 29, 2025 08:00AM Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On

Dec 12, 2025 11:00AM Cadrenal's Quiet Expansion Play Is Starting to Get Loud

Dec 12, 2025 09:45AM Cadrenal adds VLX-1005 to anticoagulation pipeline

Dec 12, 2025 09:45AM Cadrenal's Anticoagulation Platform Is Expanding in a $40 Billion Market

Nov 10, 2025 09:05AM Cadrenal Therapeutics, Inc. (CVKD) Tops Q3 EPS by 8c

Sep 15, 2025 08:02AM Cadrenal Therapeutics acquires eXIthera's Factor XIa inhibitor portfolio

Aug 11, 2025 08:02AM Cadrenal Therapeutics, Inc. (CVKD) Misses Q2 EPS by 61c

Aug 5, 2025 06:01AM Cadrenal Therapeutics plans clinical trial for tecarfarin in dialysis patients

May 15, 2025 07:31AM Cadrenal Therapeutics (CVKD) Announces Tecarfarin Manufacturing Progress in Support of Clinical Trial Readiness

May 8, 2025 08:02AM Cadrenal Therapeutics, Inc. (CVKD) Reports Q1 Loss of $2.09

Mar 4, 2025 08:05AM Cadrenal Therapeutics (CVKD) Announces Collaboration Agreement with Abbott (ABT) in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3 LVAD

Feb 6, 2025 09:01AM Cadrenal Therapeutics (CVKD) Announces Chief Medical Officer Transition

Nov 11, 2024 07:26AM Cadrenal Therapeutics (CVKD) PT Raised to $32 at H.C. Wainwright

Oct 24, 2024 09:00AM Cadrenal Therapeutics (CVKD) Announces 391.24K Share Offering at $13.15/sh

Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Aug 22, 2024 09:03AM Cadrenal Therapeutics (CVKD) Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients

Aug 20, 2024 07:11AM Cadrenal Therapeutics (CVKD) will begin trading on split-adjusted basis on August 20